
Testosterone treatment can improve sexual desire and activity in men with confirmed hypogonadism and low libido. Its effect on erections is smaller and less consistent; the TRAVERSE sexual-function study found improved desire without improved erectile function. Persistent ED needs assessment beyond testosterone, and improved sexual interest does not mean improved fertility because external testosterone can suppress sperm production.125
Key points
- Low desire and erectile dysfunction require different questions.12
- TRAVERSE found a libido benefit without an erectile-function benefit.1
- A sexual symptom response cannot confirm fertility.5
Are low libido and erectile dysfunction the same problem?
Low libido means reduced sexual interest or desire. Erectile dysfunction means difficulty achieving or maintaining an erection adequate for sexual activity. They can occur together, but they are not interchangeable. A person can want sex and have unreliable erections, or have intact erectile capacity with little interest in using it. The distinction matters because testosterone research does not show the same effect on both outcomes. 1
Testosterone is one contributor to sexual function, alongside vascular, neurological, psychological, medication, and relationship factors. The American Urological Association's erectile-dysfunction guideline recommends a medical, sexual, and psychosocial history rather than assuming a single hormonal cause. It also treats ED as a possible marker of cardiovascular disease and other health conditions. 2
Does testosterone therapy improve sexual desire?
In men with documented hypogonadism and low libido, randomized evidence supports an average improvement in sexual desire and activity. The TRAVERSE Sexual Function Study enrolled 1,161 men with low libido from the larger trial. Participants were 45-80 years old, had symptoms and two low testosterone measurements, and had cardiovascular disease or elevated cardiovascular risk. Testosterone gel improved desire and sexual activity compared with placebo, with effects maintained through two years. 1
This does not establish that treatment restores a particular frequency of sex, repairs relationship difficulties, or makes every participant satisfied. Sexual-activity scores are study measurements, and an average group difference includes people who experienced different degrees of change.
For someone considering evaluation, the relevant question is whether reduced desire is persistent, distressing, and plausibly related to a confirmed hormone deficiency. The low-testosterone symptoms guide places sexual symptoms alongside other clues.
Why might desire improve while erections do not?
An increase in sexual interest does not necessarily repair the blood-flow, nerve, or mechanical processes required for an erection. In TRAVERSE, testosterone improved desire and activity without a significant improvement in erectile function compared with placebo. 1
The earlier Testosterone Trials found improvements in several sexual measures, including a smaller improvement in erectile function. Differences in the participants, measurements, follow-up, and background illness mean that one study should not be used to erase the other. 3
For a reader, the evidence supports a realistic distinction: low desire in confirmed hypogonadism is a more consistent testosterone-responsive outcome than ED considered on its own. Persistent erection difficulty still deserves its own evaluation even when libido returns. Labeling all sexual symptoms as low T can leave vascular disease, medication effects, or another problem untreated.

Which sexual outcome does each treatment question concern?
Define the desired change before interpreting a study or judging a treatment. The following map separates outcomes that are often bundled under sexual performance. Each concern needs an assessment that matches the outcome.
| Reader concern | Relevant assessment | What testosterone evidence shows |
|---|---|---|
| Little sexual interest | Libido and distress, plus endocrine evaluation | Average desire benefit in documented hypogonadism and low-libido populations. 1 |
| Unreliable erection despite desire | ED history, vascular risk, medication and other factors | Mixed erectile-function results; no benefit in the TRAVERSE sexual substudy. 12 |
| ED medicine not sufficient | Correct use and causes of nonresponse | One optimized-sildenafil trial found no significant add-on benefit. 4 |
| Trying to conceive | Reproductive history and semen assessment when indicated | Exogenous testosterone can suppress sperm production. 5 |
Does adding testosterone make ED medicines work better?
It may be considered in selected men with confirmed deficiency, but benefit is not guaranteed. In a randomized trial of 140 men with erectile dysfunction and low testosterone, sildenafil was first optimized. Adding testosterone gel for 14 weeks did not significantly improve erectile-function scores compared with adding placebo. 4
That result answers the question of add-on therapy in that study. It does not show that testosterone has no role in a man with a genuine endocrine disorder, and it does not establish the best treatment for every person who has failed a particular ED medicine.
An individualized discussion should distinguish the reason for testosterone from the reason for an erection-specific treatment. If the hormone treatment addresses hypogonadism while a separate treatment addresses ED, each needs its own benefit assessment. Combining treatments without defining those goals makes it harder to know what helped and what caused an adverse effect.
What testing is useful when sexual symptoms persist?
A morning testosterone measurement can be part of the evaluation, but a low value requires confirmation and clinical interpretation. Persistent sexual symptoms with normal testosterone should not automatically be treated by pushing levels higher. The cause of symptoms may lie elsewhere, and a normal laboratory result does not mean the concern is unimportant. 25
The history can cover whether the problem is desire, erection reliability, ejaculation, discomfort, or several of these; whether it occurs in all situations; medication changes; sleep; and relevant medical conditions. A clinician may also review vascular risk, including blood pressure and diabetes. These details direct the evaluation more effectively than an undifferentiated request for a hormone panel. 2
Our testosterone blood-test guide explains timing and repeat measurements. If a low result persists, the cause of deficiency matters for the next decision.

Does improved libido mean fertility is better?
No. Sexual desire, erections, and sperm production are distinct outcomes. Exogenous testosterone can suppress the hormonal signals that support sperm production even when sexual interest improves. A person can feel sexually better while becoming less likely to conceive. Guidelines advise against initiating testosterone when fertility is planned in the near term. 5
This is one of the most consequential limits of using sexual performance as a shorthand for reproductive health. The ability to ejaculate does not measure sperm concentration, and appearance of semen cannot confirm fertility.
Anyone who wants children should make that goal explicit before treatment decisions. The article on testosterone and sperm production explains why a reproductive assessment may be needed and why simply stopping testosterone later does not create a predictable conception timetable.
How should sexual response be assessed over time?
Follow the original symptom separately from the hormone concentration. A useful account might distinguish interest in sex, erection reliability, distress, and satisfaction, rather than treating them as one score. Changes in partner circumstances, health, medications, or opportunity for sexual activity can also influence the experience.
A blood concentration within the intended range confirms exposure; it does not prove that a particular sexual problem should have resolved. If the initial concern remains, the next step is to reassess the diagnosis and other contributors with the clinician. Raising exposure to pursue an imagined ideal frequency of sex does not follow from the trial evidence.
A sexual benefit needs to be named specifically. More desire, more activity, improved erection scores, and improved fertility are four different claims. The randomized studies support some of them in specific populations and do not justify treating the others as automatic consequences. 134
Common questions
Can I have normal testosterone and erectile dysfunction?
Yes. ED has vascular, neurological, medication-related, psychological, and other contributors. A normal hormone result does not exclude a treatable erection problem.2
Does an erection problem automatically justify TRT?
References
- 1.Pencina et al. Effect of Testosterone Replacement Therapy on Sexual Function and Hypogonadal Symptoms in Men with Hypogonadism. JCEM. 2024.
- 2.American Urological Association. Erectile Dysfunction: AUA Guideline. 2018.
- 3.Snyder et al. Effects of Testosterone Treatment in Older Men. NEJM. 2016.
- 4.Spitzer et al. Effect of testosterone replacement on response to sildenafil citrate in men with erectile dysfunction: a parallel, randomized trial. Annals of Internal Medicine. 2012.
- 5.Bhasin et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. JCEM. 2018.
This article is for general education, not medical advice, diagnosis or a treatment recommendation. A licensed clinician can interpret the evidence in the context of your symptoms, tests, medicines and fertility plans.